KLF5 and breast carcinoma: Studies have indicated that KLF5 is abnormally expressed in various solid tumors, including breast cancer, prostate cancer, colon cancer, non-small cell lung cancer, and esophageal squamous cell carcinoma, driving the progression and metastasis of these tumors [22].